| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.2 |